Novel ferritin-based siRNA delivery system shows promise for targeted glioblastoma therapy
A new study led by Profs. Fan Kelong and Yan Xiyun from the Institute of Biophysics of the Chinese Academy of Sciences introduces a novel ferritin-based delivery system for small interfering RNA (siRNA) targeting glioblastoma (GBM), a breakthrough that could enhance RNA interference (RNAi) therapies for cancer treatment.
A new study led by Profs. Fan Kelong and Yan Xiyun from the Institute of Biophysics of the Chinese Academy of Sciences introduces a novel ferritin-based delivery system for small interfering RNA (siRNA) targeting glioblastoma (GBM), a breakthrough that could enhance RNA interference (RNAi) therapies for cancer treatment.
